Michael Gorzynski

CIK 1812551 · last filed 2024-03-21

Michael Gorzynski is a corporate insider who has filed 8 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for VATE, was dated Mar 21, 2024. Across all open-market trades the lifetime net is +$404.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $177.8M across reported positions. 12 SEC filings were submitted jointly with GENERAL INSURANCE CO CONTINENTAL.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$177.82M

Companies

3

Total Filings

8

Lifetime Open-Market Net

$404.3K

Filer Profile

Reported Address
595 MADISON AVE
30TH FLOOR
NEW YORK, NY 10022
Related Filers
GENERAL INSURANCE CO CONTINENTAL — 12 joint filings, latest 2026-08-25
Continental General Holdings LLC — 12 joint filings, latest 2026-08-25
Continental Insurance Group, Ltd. — 12 joint filings, latest 2026-08-25
MG Capital Management Ltd. — 12 joint filings, latest 2026-08-25
Percy Rockdale LLC — 12 joint filings, latest 2026-08-25
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VATE 10%+ Owner $7.44 $0 1 2024-03-21
AMR Director 788,880 $225.41 $177.82M $0 1 2023-06-08
INNOVATE Corp. (HCHC) Delisted Director 5,129,520 $3.68 $18.88M $404.3K 6 2021-07-06

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-03-21 VATE Sell (S) $0 EDGAR
2023-06-08 AMR Exer (X) +31,650 $1.42M EDGAR
2021-07-06 INNOVATE Corp. (HCHC) Delisted Other (J) $0 EDGAR
2021-06-28 INNOVATE Corp. (HCHC) Delisted Grant (A) +22,556 $0 EDGAR
2020-12-08 INNOVATE Corp. (HCHC) Delisted Exer (X) +2,259,080 $5.13M EDGAR
2020-11-24 INNOVATE Corp. (HCHC) Delisted Exer (X) +2,176,621 $4.94M EDGAR
2020-08-03 INNOVATE Corp. (HCHC) Delisted Grant (A) +33,747 $0 EDGAR
2020-06-17 INNOVATE Corp. (HCHC) Delisted Buy (P) +110,600 $404.3K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.